Different sympathetic pathways control the metabolism of distinct bone envelopes

详细信息	查看全文 | 推荐本文 |

• 作者：Caroline Bataille^a ; ^c ; ^{caroline.bataille@parisdescartes.fr} ; Cé ; dric Mauprivez^a ; ^c ; ^{mauprivez.cedric@free.fr} ; Eric Haÿ ; ^b ; ^{eric.hay@inserm.fr} ; Brigitte Baroukh^a ; ^{maya.baroukh@parisdescartes.fr} ; Adrian Brun^a ; ^{adrian.brun@etu.parisdescartes.fr} ; Catherine Chaussain^a ; ^c ; ^{catherine.chaussain@parisdescartes.fr} ; Pierre J. Marie^b ; ^{pierre.marie@inserm.fr} ; Jean-Louis Saffar^a ; ^c ; ^{jean-louis.saffar@parisdescartes.fr} ; Marc Cherruau^a ; ^c ; ^{marc.cherruau@parisdescartes.fr}
• 关键词：Catecholaminergic pathway ; Cholinergic pathway ; Vasoactive Intestinal Peptide ; Periosteum ; Trabecular bone ; Osteoclast precursors ; Sympathectomy
• 刊名：Bone
• 出版年：2012
• 期刊代码：39_87563282
• 类别：med
• 出版时间：May, 2012
• 卷：50
• 期：5
• 页码：1162-1172
• 文件大小：3258 K

摘要

Bone remodeling, the mechanism that modulates bone mass adaptation, is controlled by the sympathetic nervous system through the catecholaminergic pathway. However, resorption in the mandible periosteum envelope is associated with cholinergic Vasoactive Intestinal Peptide (VIP)-positive nerve fibers sensitive to sympathetic neurotoxics, suggesting that different sympathetic pathways may control distinct bone envelopes. In this study, we assessed the role of distinct sympathetic pathways on rat femur and mandible envelopes. To this goal, adult male Wistar rats were chemically sympathectomized or treated with agonists/antagonists of the catecholaminergic and cholinergic pathways; femora and mandibles were sampled. Histomorphometric analysis showed that sympathectomy decreased the number of preosteoclasts and RANKL-expressing osteoblasts in mandible periosteum but had no effect on femur trabecular bone. In contrast, pharmacological stimulation or repression of the catecholaminergic cell receptors impacted the femur trabecular bone and mandible endosteal retromolar zone. VIP treatment of sympathectomized rats rescued the disturbances of the mandible periosteum and alveolar wall whereas the cholinergic pathway had no effect on the catecholaminergic-dependent envelopes. We also found that VIP receptor-1 was weakly expressed in periosteal osteoblasts in the mandible and was increased by VIP treatment, whereas osteoblasts of the retromolar envelope that was innervated only by tyrosine hydroxylase-immunoreactive fibers, constitutively expressed beta-2 adrenergic receptors. These data highlight the complexity of the sympathetic control of bone metabolism. Both the embryological origin of the bone (endochondral for the femur, membranous for the mandibular periosteum and the socket wall) and environmental factors specific to the innervated envelope may influence the phenotype of the sympathetic innervation. We suggest that an origin-dependent imprint of bone cells through osteoblast-nerve interactions determines the type of autonomous system innervating a particular bone envelope.